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Objective. The aim of this study was to compare the effectiveness of denture microwave disinfection and antifungal therapy
on treatment of denture stomatitis.
Study Design. Sixty denture wearers with denture stomatitis (3 groups; n  20 each), were treated with nystatin or denture
microwave disinfection (1 or 3 times/wk) for 14 days. Mycologic samples from palates and dentures were quantified and
identified with the use of Chromagar, and clinical photographs of palates were taken. Microbiologic and clinical data were
analyzed with the use of a series of statistical tests (  .05).
Results. Both treatments similarly reduced clinical signs of denture stomatitis and growth on palates and dentures at days 14
and 30 (P  .05). At sequential appointments, the predominant species (P  .01) isolated was C. albicans (range 98%-53%),
followed by C. glabrata (range 22%-12%) and C. tropicalis (range 25%-7%).
Conclusions. Microwave disinfection, at once per week for 2 treatments, was as effective as topical antifungal therapy for
treating denture stomatitis. (Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:469-479)Denture stomatitis is the most common oral opportu-
nistic infection on the palate in elderly denture wear-
ers.1–3 This recurring disease is mainly caused by Can-
dida species. Candida albicans is the major pathogen in
oral candidiasis,4–6 but non-albicans species can also
contribute to the development of this infection.4–8
Apart from many other factors, candidal adherence to
oral epithelia9 and denture surface5,8,10 is a crucial first
step in the initiation and development of denture sto-
matitis. Candidal adherence is reported to be enhanced
by the transition from blastospores to hyphae,11 a pro-
cess that contributes to the virulence of this pathogen.12
In addition, the roughness of acrylic denture surface
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http://dx.doi.org/10.1016/j.oooo.2012.05.006might affect plaque retention or inhibit its removal, and
therefore dentures act as reservoirs for yeasts, which
may be aggravated by poorly fitting and old den-
tures.5,8,10
The treatment of denture stomatitis involves oral and
denture hygiene,2 removing dentures at night,10 correc-
tion of denture faults,13 and the use of topical and
systemic antifungal agents, such as amphotericin B,
nystatin, and azoles.10,14–18 Amphotericin B and nys-
tatin are used topically and sometimes applied to the
denture-fitting surface before its insertion,19 whereas
azoles such as fluconazole, itraconazole, and ketacona-
zole are available for systemic antifungal treat-
ment.16,17 There are, however, a few issues in relation
to the use of these agents. Poor response to topical
antifungal drugs is not uncommon,10 owing to the di-
lution and rapid elimination of topically applied drugs
by the flushing action of saliva, which can reduce
antifungal agents to subtherapeutic concentrations.14 In
addition, these drugs require multiple doses, which can
Statement of Clinical Relevance
This clinical study showed that weekly denture mi-
crowave disinfection was as effective as nystatin
antifungal therapy in reducing both the clinical and
microbiological signs of denture stomatitis. Patients
appear to benefit from such protocol for several
months.469
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drugs are expensive13 and may present some limitations
in terms of toxicity20 and drug interactions. Further-
more, the widespread use of systemic medications has
resulted in the development of resistant species.21,22
Strict denture disinfection procedures are recom-
mended to treat and prevent denture stomatitis.8,10,14,17
Within this context, microwave irradiation has proved
to be a safe, simple, effective, and low-cost disinfection
method that can be used not only to disinfect den-
tures,23–27 but also for the treatment of denture stoma-
titis.8,10,14,18 Some studies have shown that irradiation
of complete dentures for 1,14 6,10 or 108 minutes,
associated or not with the use of topical antifungal
therapy (nystatin14 and miconazole10), significantly re-
duced the number of microorganisms found in the
dentures, as well as the clinical symptoms affecting the
palatal mucosa of patients with denture stomatitis. In
addition, denture microwaving was an effective means
of reducing the invasive form of Candida species
(pseudohyphae) from both the dentures and the surface
of the patient’s palate.10,14 It is important to point out
that this method presents an important advantage in
antifungal therapy, in that it is a physical method of
disinfection that eliminates the possibility for the sur-
vival of microorganisms and selection of resistant
yeasts as occurs with systemic and topical antifun-
gals.8,10,14,17
Despite the fact that the methods of disinfection
through microwaves used in earlier studies8,10,14,27 are
considered to be effective for the sterilization of com-
plete dentures and the treatment of denture stomatitis, it
has been demonstrated that the heat generated during
microwave irradiation can increase the contraction of
the acrylic resins28,29 and accelerate the water sorption
and solubility processes of these materials.30 There
have also been reports of undesirable effects on me-
chanical properties in denture base resins after micro-
wave disinfection for 6 minutes.31–34 Therefore, in vitro
and in vivo studies were conducted to evaluate both
antimicrobial efficacy and effects on acrylic resins of
microwave disinfection with the use of reduced irradi-
ation times. A microwave disinfection regimen of 3
minutes at 650 W has proved to have no detrimental
effect on several mechanical properties of acrylic res-
ins.35–40 Moreover, this lower exposure time was ef-
fective for sterilizing test samples contaminated with C.
albicans, Pseudomonas aeruginosa, Bacillus subtilis,
and Staphylococcus aureus23,24 and complete dentures
contaminated with different species of Candida, includ-
ing the intrinsically resistant C. glabrata and C. kru-
sei26 and methicillin-resistant S. aureus.41 When used
in a clinical trial, this disinfection protocol was effec-
tive in inactivating denture biofilms in individuals with-out denture stomatitis.25 Despite these favorable re-
sults, the efficacy of denture microwave disinfection for
3 minutes in the treatment of denture stomatitis has
been evaluated by only a single study.18 Furthermore,
the length of treatment and the frequency of denture
irradiation would be other factors to consider when
using this method of treatment. In the few clinical
studies available,8,10,14,18 the frequency of the disinfec-
tion cycles varied from 1 to 7 times per week for
periods ranging from 1 to 4 weeks. Considering that the
protocol for microwave disinfection (3 minutes at 650
W) can promote complete disinfection of the den-
tures,23,25,26 a reduction in the frequency of the irradi-
ation would be possible, making the treatment more
convenient by reducing the number of patient visits to
the dentist. Therefore, the present clinical study evalu-
ated the effectiveness of 2 frequencies of denture mi-
crowave disinfection to treat patients with denture sto-
matitis and compared them with topical antifungal
therapy (nystatin). The hypothesis tested was that there
would be no differences among treatments. The effec-
tiveness was assessed microbiologically, through the
reduction in Candida counts on the palates and denture
surfaces, and clinically, by means of resolving the
clinical signs of the infection. The prevalence of Can-
dida spp. identified in these patients was also evaluated.
MATERIALS AND METHODS
Study design
This study was a 3-group repeated-measures design with
random assignment of subjects to treatment groups to
compare the effectiveness of denture microwave disinfec-
tion and nystatin in the treatment of patients with denture
stomatitis. This research was conducted in accordance
with the Declaration of Helsinki, and its protocol was
approved by the Ethics Committee of the Araraquara
Dental School, UNESP-Univ Estadual Paulista. Each of
the subjects voluntarily entered the study and signed an
informed consent form before enrollment.
Participants
The studied population consisted of patients from the
Araraquara Dental School. Only patients wearing a
maxillary complete denture, 30-75 years old, and as-
sessed for clinical evidence of denture stomatitis were
included. The exclusion criteria for patient selection
were as follows: having undergone antibiotic, steroid,
or antifungal therapy in the preceding 3 months; with
anemia or immunosuppression or undergoing cancer
therapy (radio- or chemotherapy); and wearing the
same complete denture for 30 years.18 Full personal,
medical, and dental/denture histories were collected
from all of the patients. A comprehensive oral exami-
nation of each patient was performed by the same
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sified according to the criteria proposed by Newton42:
0, absence of palatal inflammation; 1 (type I), petechiae
dispersed throughout all or any part of palatal mucosa
in contact with the denture (localized simple inflamma-
tion); 2 (type II), macular erythema without hyperplasia
(generalized simple inflammation); and 3 (type III),
diffuse or generalized erythema with papillary hyper-
plasia (inflammatory papillary hyperplasia).
Sample size calculation and randomization
Using data from 2 clinical studies published by the
authors’ research group,10,18 sample size calculation
resulted in a minimal sample size of 20 patients in each
group. To create groups of patients that were similar
regarding baseline characteristics that could influence
prognosis other than the treatment being considered,
namely, risk factors, a stratified randomization was
used. The following risk factors were considered in this
study: age of the dentures,1 smoking habits,43 xerosto-
mia,1 denture hygiene habits,2 and nocturnal wear of
the dentures.1 Denture hygiene was classified as good
(absence of plaque) or poor (presence of removable
and/or nonremovable plaque on the inner and/or outer
denture surface).18
Interventions
According to the stratified randomization list, the 60
patients were randomly assigned to one of the 3 exper-
imental groups. Patients in the NYS group received
topical antifungal medication (nystatin; Cristália,
Produtos Químicos Farmacêuticos, Itapira, Brazil). Pa-
tients were instructed to remove their dentures from the
oral cavity and rinse with 1 mL of the suspension
(100,000 UI/mL) for 1 minute, 4 times per day, for 14
days. Patients were informed not to swallow the sus-
pension after rinsing. In the MW1 and MW3 groups,
the maxillary complete denture of each patient was
individually immersed in a 600-mL beaker containing
200 mL sterile distilled water. Each beaker was placed
on the rotational plate in a domestic microwave oven
(Sensor Crisp 38; Brastemp, Double Emission System,
Manaus, Brazil) and irradiated at 650 W for 3 min-
utes23,25,26 1 time (MW1) or 3 times (MW3) per week
for a period of 14 days. After treatment, all patients
were followed monthly for 3 months. Over the exper-
imental period, all patients were instructed to scrub
their dentures with coconut soap followed by toothpaste
before sleeping and after every meal. They were also
instructed to remove their dentures and leave them
immersed in filtered water (200 mL) while they were
asleep.10,18Outcomes
The primary outcomes of interest were the Candida
colony counts from the palates and dentures surfaces,
quantified in cfu/mL, and severity of infection of the
palatal mucosal, classified according to the criteria pro-
posed by Newton42 (0, absence of palatal inflammation;
or types I, II, and III), measured before treatments
(baseline), at the end of the treatments (day 14), and at
follow-ups (days 30, 60, and 90). The secondary out-
come was the prevalence of Candida spp. identified in
the 3 groups of patients at the same intervals.
Microbiologic investigations
Before treatments (day 0), mycologic samples were
obtained from the palatal mucosa and the tissue side of
the maxillary dentures of each patient in all 3 groups by
rubbing with a sterile swab.5,8,10,17,18,25 Mycologic
samples were also taken after treatments started (day
14) and at follow-ups (days 30, 60, and 90). Each swab
was put into a test tube containing 10 mL 0.9% sterile
saline solution and vortexed for 1 minute to suspend the
organisms from the swab. Thereafter, samples from this
suspension were cultured on Sabouraud dextrose agar
(SDA) containing 0.05% chloramphenicol for yeast
growth, and in Chromagar Candida5,18,25 for isolation
and presumptive identification of Candida species. The
plates were incubated at 30°C for 5 days. Candida spp.
colonies counts were quantified (cfu/mL) with the use
of a digital colony counter (Phoenix CP 600 Plus). All
the different colony types observed on Chromagar
plates were selected and reinoculated onto SDA for
purity. The isolated colonies were identified by chla-
mydospore production on corn meal agar supplemented
with 1% Tween-80 and by the carbohydrate assimila-
tion pattern by using the ID 32C (bioMérieux, Marcy
l’Etoile, France).5,8,18 In addition, a hypertonic Sab-
ouraud broth test was required to distinguish C. albi-
cans from C. dubliniensis.44 All microbiologic proce-
dures were carried out by the same operator.
Clinical investigation and blinding
To document the clinical response to the treatments, stan-
dardized color photographs were taken of the palatal mu-
cosa of each patient. These photos were taken before
treatments (day 0), at the end of treatments (day 14), and
at follow-ups (days 30, 60, and 90). All of the photographs
were taken with the same digital camera (Cybershot DSC-
F717; Sony, Tokyo, Japan), by the same operator and
under the same conditions (place, light, angle, and patient
position) to facilitate their reproducibility. After standard-
ization of the images, 2 independent observers were en-
gaged to blindly analyze the 5 photographs taken of each
patient.18 In this blind analysis, the observers were in-
structed to classify the mucosal characteristics of each
ORAL MEDICINE OOOO
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absence of palatal inflammation; or types I, II, and III).
Observers were blind to risk factors, treatment group, and
period of evaluation.
Statistical analysis
Demographic characteristics of the patients and the risk
factors were statistically analyzed to ensure homogeneity
between the groups using one-way analysis of variance
(ANOVA) and Fisher exact tests. In the microbial analy-
ses, the numbers of cfu/mL were log10 transformed (log10
cfu/mL) to achieve a normal distribution, and a 2-way
ANOVA using a random effects statistical model was
performed. Two factors were considered for analysis:
treatment (NYS, MW1, and MW3) and period of time
(baseline, day 14, day 30, day 60, and day 90). The values
obtained from the palates and dentures were analyzed
separately. When differences were found, Tukey post hoc
test was implemented and P  .05 was taken to be
significant. Clinical significance of the 3 treatments on the
microbiologic reduction on the palates and dentures was
also evaluated by the treatments’ effect size45: 0.1 
trivial effect; 0.1-0.3  small effect; 0.3-0.5  moderate
effect; and 0.5  large difference effect.10,18 The fre-
quency distributions of the different species of Candida
isolated from the patients were analyzed by means of a 2
test, Bonferroni-corrected confidence interval, and Bon-
ferroni-Holm correction for multiple testing. Also, an
odds ratio (OR) was calculated comparing the absence or
presence of mixed Candida spp. isolated from the palates
with that isolated from the dentures.
For the clinical data analysis, the degrees of correlation
and concordance of the 2 blind observers were estimated
to provide a measure of the reliability and validity of the
results. The tests used for this analysis were the kappa
measure of agreement, ranging from 0 to 1 (perfect match:
  1; almost perfect: 0.81    1; substantial: 0.61 
  0.80; moderate: 0.41    0.60; fair: 0.21   
0.40; slight: 0   0.20; no concordance:   0),46 the
Kendall rank correlation coefficient, ranging from1 to 1
Table I. Demographic characteristics and risk factors
Demographic
characteristic
Mean age (y) % female
Mean age of
dentures (y)
% of patien
xerostom
NYS 62.5 90 18.6 65
MW1 59.5 85 17.4 40
MW3 56.8 80 12.8 50
P value .1420* .9187† .3160* .5020
*One-way ANOVA (age of patients: Shapiro-Wilks test: P  .1795;
.0001; Bartlett test: P  .9721).
†Fisher exact test.(perfect agreement:   1; no correlation:   0; perfectdisagreement:   1),47 and the coefficient of concor-
dance (%). The degrees of severity of the mucosal char-
acteristics of patients scored at baseline from the NYS,
MW1, and MW3 groups were compared by Fisher exact
test to ensure homogeneity between the groups (  .05).
To analyze the magnitude of the treatment effect on
the evolution of the disease over time, a categoric variable
was created.18 The following general categories were
used: decrease in infection scored by 1 point (	, i.e., type
III to II, type II to I, or type I to 0), 2 points (		, i.e.,
type III to I, or type II to 0), or 3 points (			, i.e., type
III to 0); no change in infection status (No); and increase
in infection scored by 1 point (, i.e., type I to II, or type
II to III) or 2 points (, i.e., type I to III). The percent-
age of patients in each category was determined for each
period, and comparisons between the groups were made
by Kruskal-Wallis test (  .05). The percentages of
“cured patients” and “patients with recurrence” were also
compared among groups by means of the Fisher exact
test. In all analyses, differences were considered to be
statistically significant at a value of P  .05.
RESULTS
Participants, demographic characteristics and risk
factors
Table I shows the demographic and clinical character-
istics of the subjects. The mean age of the patients
ranged from 56.8 to 62.5 years at the time of the initial
evaluation, and more women than men were present in
the 3 study groups. In all groups, the dentures were
made 10 years before the trial. In addition, 40% of
patients complained of xerostomia and few smokers
participated. Before the onset of the study, a large
percentage of patients wore their dentures at night and
most of them showed poor denture hygiene habits.
Stratified randomization ensured that the subsamples
for the 3 treatments were well balanced for both demo-
graphic characteristics and risk factors, because the
statistical analysis showed homogeneity among the
Risk factors
% nonsmokers
% with nocturnal wear
of dentures
% with poor hygiene
habits
90 90 80
90 90 70
80 90 65
.7105† .9999† .6752†
t test: P  .9010; age of patients’ dentures: Shapiro-Wilks test: P ts with
ia
†
Bartletthree groups of study (P  .05).
5).
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dropped out or were excluded from the trial (4 from the
group NYS, 3 from the group MW1, and 2 from the
group MW3) because of the need for antibiotic treat-
ment (5 patients) or withdrawal of consent to partici-
pate (4 patients).
Microbiologic results
Two-way ANOVA (Table II) showed that, regardless of
the period of time, there were no significant differences in
the mean values of log10 cfu/mL when the factor treatment
group (NYS, MW1, or MW3) was analyzed for the den-
tures (P  .3556) and for the palates (P  .0677). 2 test
and Bonferroni confidence intervals showed significantly
more yeast-negative samples (P .00001) collected from
the palates (47.2%, 95% Bonferroni-corrected confidence
interval [CI] 0.40-0.53) compared with samples from the
dentures (22.5%, 95% Bonferroni-corrected CI 0.16-
0.28). When the factor period of time was evaluated,
significant differences (P  .0001) were found for both
palates and dentures (Table II). There was no interaction
between the factors of treatment group and period of time
for the dentures (P  .8785) and for the palates (P 
.0837).
The mean values of the quantitative mycologic cul-
tures (log10 cfu/mL) of Candida spp. with reference to
the palatal mucosa and internal surface of the complete
Table II. ANOVAs using a random effects statistical m
dentures
Numerator df
Palates
(Intercept) 1
Period of time 4
Treatment 2
Interaction time  treatment 8
Dentures
(Intercept) 1
Period of time 4
Treatment 2
Interaction time  treatment 8
aSignificant difference (P  .05).
Table III. Mean values and standard deviation of Ca
dentures after treatments and values of treatment effec
Group Location Baseline Day 14
NYS Palate 1.95 (1.53) 0.26 (0.65)a 0
Denture 4.24 (0.73) 1.58 (1.79)a 2
MW1 Palate 0.96 (1.17) 0.52 (0.98)a 1
Denture 4.34 (1.05) 1.46 (1.88)a 2
MW3 Palate 1.72 (1.45) 0.80 (1.43)a 1
Denture 4.43 (1.22) 1.65 (1.73)a 3
aSignificant difference from baseline by Tukey post hoc test (P  .0dentures are presented in Table III. Tukey post hoc testshowed that all treatments reduced significantly the
mean values of log10 cfu/mL from the palates (P 
.001) and dentures (P  .001) at day 14 and day 30 (P
values .007 and .050, respectively). The reduction was

3-fold for the dentures and 2.7-fold for the palates. At
days 60 and 90, an increase in the mean values of log10
cfu/mL from the palates and dentures was observed
compared with baseline (P  .05). Table III shows that
the effect size of treatments was large for the palates
and very large for the dentures after all treatments.
Table IV demonstrates that regardless of the group
and in all trial periods C. albicans was the predominant
yeast (2 test: P  .00001). C. glabrata and C. tropi-
calis were the non-albicans species most frequently
isolated, with no statistical differences between them
(P  .05). Although a significant decrease (P  .01) in
the prevalence of C. albicans was observed at day 14
and follow-up periods, no significant change was ob-
served for C. tropicalis and C. glabrata. Other Candida
species (lusitanae, colliculosa, famata, parapsilosis,
krusei, rugosa, zeylanoides, intermedia, sphaerica, ke-
fyr, and guilliermondii) and additional yeasts from the
genus Cryptococcus (laurentii, humicola, and albidus),
Saccharomyces (cerevisiae), Kloeckera apiculata, and
Rhodotorula were detected at low rates (from 1.6% to
13.3% of patients).
Twenty-nine participants (48.3%) had 1 species
for mean values of log10 ufc/mL from the palates and
Denominator df F value P value
212 56.9892 .0000
212 8.6790 .0000a
57 2.8242 .0677
212 1.7734 .0837
212 705.9835 .0000
212 19.8406 .0000a
57 1.0528 .3556
212 0.4669 .8785
colony counts in log10 cfu/mL from the palates and
Treatment effect size0 Day 60 Day 90
7)a 1.41 (1.56) 1.17 (1.28) 1.78
8)a 3.46 (1.91) 3.31 (2.18) 2.09
1)a 1.51 (1.50) 1.05 (1.20) 0.51
3)a 3.16 (2.04) 3.24 (1.71) 2.95
1)a 1.32 (1.57) 2.01 (1.53) 1.17
4)a 3.84 (1.58) 4.24 (1.37) 3.08odelndida
t size
Period
Day 3
.81 (1.4
.87 (1.9
.01 (1.2
.63 (2.0
.28 (1.3
.04 (2.1of yeast isolated from the samples: 11 from the NYS
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(MW1 and MW3). The yeast mixtures isolated were
C. albicans 	 C. glabrata (38%), C. albicans 	 C.
tropicalis (27%), and C. albicans 	 C. glabrata 	
C. tropicalis (12%). In addition, the frequency dis-
tributions of mixed samples isolated from the den-
tures (52.2%) were significantly higher (2 test: P 
.0115) than those obtained from the palates (34.8%).
Calculation of the OR indicated that the dentures
were both 3 times more likely to have Candida spp.
colonization (OR 3.06;   .05) and 2 times more
likely to have mixed populations of Candida spp.
Table IV. Frequency distributions (%) of Candida spp.
identified at baseline and at follow-ups
Species
Period
Baseline Day 14 Day 30 Day 60 Day 90
C. albicans 98Aa 53Ba 69Ba 72Ba 71Ba
C. glabrata 22Ab 12Ab 14Ab 17Ab 18Ab
C. tropicalis 25Ab 7Ab 7Ab 15Ab 20Ab
2: baseline: P  .7149; day 14: P  .5207; day 30: P  .4214; day
60: P  .8397; day 90: P  .8365. 95% Bonferroni-corrected
confidence interval: baseline: C. albicans 0.94-1.0, C. tropicalis
0.11-0.38, and C. glabrata 0.08-0.34; day 14: C. albicans 0.37-
0.68, C. tropicalis 0.0-0.14, and C. glabrata 0.01-0.21; day 30: C.
albicans 0.56-0.82, C. tropicalis 0.0-0.13, and C. glabrata 0.04-
0.23; day 60: C. albicans 0.59-0.85, C. tropicalis 0.04-0.25, and
C. glabrata 0.05-0.27; day 90: C. albicans 0.57-0.84, C. tropicalis
0.07-0.31, and C. glabrata 0.06-0.29). Horizontally, values des-
ignated with the same uppercase superscript letter were not sta-
tistically different (Bonferroni-Holm test: P  .05). Vertically,
values designated with the same lowercase superscript letter were
not statistically different.
Table V. Values of kappa measure of agreement (),
Kendall rank correlation coefficient (), and coefficient
of concordance (%) for each period of time for the 3
groups of study
Group
Period of
time  
Coefficient of
concordance
NYS Day 0 0.827 0.874 94.12
Day 14 0.915 0.960 94.12
Day 30 1 1 100
Day 60 0.901 0.838 93.75
Day 90 0.889 0.948 92.31
MW1 Day 0 1 1 100
Day 14 1 1 100
Day 30 1 1 100
Day 60 0.913 0.954 94.74
Day 90 1 1 100
MW3 Day 0 0.699 0.756 90
Day 14 1 1 100
Day 30 1 1 100
Day 60 0.839 0.873 89.48
Day 90 0.923 0.957 94.45than the palates (OR 2.03;   .05).Clinical results
The examination scores assigned by the blind observers
were in high degree of correlation and concordance
(Table V). Illustrative images of the photos scored by
the observers are shown in Figure 1, and a comprehen-
sive description of the frequency distribution of the
Newton classification for denture stomatitis over the
time is given in Figure 2. Fisher exact test showed
homogeneity from the groups of study (P  .7961) for
the mucosal characteristics of patients at baseline.
Kruskal-Wallis test showed no significant differences
(P  .05) among the magnitude of the clinical efficacy
of NYS, MW1, and MW3 on the evolution of the
disease over the time (Table VI). All treatments were
considered to be successful in treating denture stoma-
titis, with 65% of patients showing improvement in
clinical signs of denture stomatitis at the end of the
treatment period (day 14). This feature was maintained
up to day 60, when 50% of all treated patients
showed a decrease in the degree of denture stomatitis.
Although none of the treated patients showed any in-
crease in the rate of infection at the end of the follow-up
period (day 90), 45%-60% of them showed a decrease
in the rate of infection (Table VI). Fisher exact test also
showed that there were not significant differences in the
percentage of “cured patients” or “patients with recur-
rence” among the 3 groups of treatment (Table VII).
DISCUSSION
The mean age of the patients assessed in the present
study (59.6 years) is in agreement with those of earlier
studies,5,10,18 which suggests a higher prevalence of
denture stomatitis after the sixth decade of life due to
the high number of complete and partial dentures wear-
ers in this age group. Also in agreement with earlier
investigations,1,3,5,10,18 there was a predominance of
female patients with denture stomatitis compared with
male patients. This difference has been attributed to
hormonal changes, especially in the period after meno-
pause48 as well as women seeking dental treatment
more frequently than men.49
The age of the dentures is another factor that favors
the development and recurrence of denture stomati-
tis.3,5,10 In the present study, the mean age of dentures
was10 years. Recently, it was reported that only 25%
of individuals using dentures for 1 year were diag-
nosed with denture stomatitis, whereas 84% of those
using dentures for 5 years had the disease.3 In the
present investigation, a large percentage of patients
complained of xerostomia and were nonsmokers, and
most of them did not remove the dentures for sleeping
and showed poor denture hygiene habits. Although not
sufficient to treat denture stomatitis,10 denture and oral
hygiene, including the removal of dentures for sleeping,
ay 90
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on dentures, as well as oral health. Therefore, these
instructions were continuously given to patients during
this study. Because the statistical analysis showed ho-
mogeneity among the 3 groups evaluated, the potential
contribution of these risk factors in the results was
probably eliminated.
From the microbiologic and clinical assessments at
the end of treatments (14 days) and follow-ups (30, 60,
and 90 days), the present in vivo study found that
microwave irradiation for disinfecting complete den-
tures, which were immersed in water during the irradi-
ation (3 minutes at 650 W), was as effective as topical
antifungal therapy with nystatin in the treatment of
denture stomatitis. The results of quantitative myco-
logic cultures revealed a significant reduction in the
cfu/mL values at the end of the treatments (day 14) in
all of the groups evaluated. Thus, the use of denture
microwave disinfection should be sufficient for many
Fig. 1. Palatal mucosa of a patient from the (A-E) NYS, (F-
day 14, (C, H, M) day 30, (D, I, N) day 60, and (E, J, O) d
Fig. 2. Number of patients from (A) NYS, (B) MW1, and (C)
stomatitis.patients with denture stomatitis, without the need ofdrugs, which should be reserved for more complicated
situations. Nystatin is a polyene antifungal agent that
binds to sterol components of the cell membrane to
alter membrane permeability and allow outward leak-
age of vital intracellular components.50 This alteration
reduces the growth and multiplication of fungal cells
and the adherence capacity of Candida to the epithelial
cells and denture surfaces.9,19 In terms of clinical ap-
plication, however, the action of topical antifungal
agents may be reduced due to the diluent effects of
saliva and tongue movement.14 The multiple daily dos-
ing regimen of this topical agent and its unpleasant taste
may have implications for compliance.16 Furthermore,
it is mainly designed to treat the oral mucosa. Despite
these shortcomings, nystatin was effective in reducing
Candida oral colonization, and no significant differ-
ences were noted among the treatment groups.
The results from the denture microwave disinfection
groups are similar to those from other clinical studies in
1, and (K-O) MW3 groups at (A, F, K) baseline, (B, G, L)
, respectively.
groups scored according to the Newton criteria42 for dentureJ) MWMW3which denture microwave irradiation was used in the
to day
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Hill14 associated microwave irradiation (1 minute at
850 W) of complete dentures with the use of topical
nystatin and observed that the method was effective in
reducing the quantity of invasive forms of C. albicans
(pseudohyphae) found on the palatal mucosa of patients
with denture stomatitis. During treatment (14 days), the
complete dentures were submitted to 3 disinfection
cycles and the patients used nystatin 3 times a day.
Webb et al.8 observed that, without the use of nystatin,
daily denture microwave disinfection (10 minutes at
350 W) for a week significantly reduced the number of
Candida spp. in complete dentures and in the palate of
patients diagnosed with denture stomatitis. Likewise, in
Table VI. Percentage of patients allocated to each cat
Period of time* Category NYS
Day 14 (n  20)
	 40
		 25
			 0
No 25
 10
 0
Day 30 (n  16)
	 56.25
		 31.25
			 0
No 12.5
 0
 0
Day 60 (n  16)
	 37.5
		 18.75
			 6.25
No 37.5
 0
 0
Day 90 (n  16)
	 31.25
		 6.25
			 6.25
No 56.25
 0
 0
*The degree of severity of the infection scored on each period (day
†Kruskal-Wallis test (  .05).
Table VII. Percentage of patients cured and with recu
Group
Cure
Day 14 Day 30
NYS 25 43.75
MW1 41.18 47.06
MW3 38.89 27.78
P value .5786 .4549
*The degree of severity of the infection scored at day 90 in relationthe present study, 6 disinfection cycles (MW3 group)significantly reduced the cfu/mL values in both denture
and palate after 14 days. In fact, only 2 disinfection
cycles during 14 days (MW1 group) were sufficient to
decrease the fungal load from dentures and palate. The
advantage of such a protocol is a reduced number of
patient visits compared with MW3. In another clinical
study,10 in which the dentures were irradiated at 650 W
for 6 minutes, 3 times a week for 30 days, no mycelial
forms and viable colonies of Candida spp. were de-
tected after 2 weeks from the beginning of the treat-
ment, regardless of the use of a topical antifungal
(miconazole). These results supported the choice of 14
days of treatment as adopted in the present study.
According to the results of the biochemical identifi-
in each period for the 3 groups
Group
P value†MW1 MW3
(n  20) (n  20) .9954
40 50
30 20
0 5
30 20
0 5
0 0
(n  17) (n  18) .9393
35.29 50
41.18 11.11
0 5.56
23.53 33.33
0 0
0 0
(n  17) (n  18) .9862
11.76 44.44
47.06 16.67
0 0
35.29 33.33
5.88 5.56
0 0
(n  17) (n  18) .9745
41.18 38.89
23.53 22.22
0 0
35.29 38.89
0 0
0 0
, 60, and 90) was compared with that scored at baseline.
, for all groups
Recurrence
y 60 Day 90 Day 90–day 60/30/14*
18.75 50
8 23.53 52.94
7 22.22 38.89
029 .999 .7755
14, 30, or 60.egory
s 14, 30rrence
Da
25
41.1
16.6
.3cations of Candida species, C. albicans was the most
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uals with clinical diagnosis of denture stomatitis. There
are several reports in the literature showing that C.
albicans is much higher than non-albicans species in
individuals with denture stomatitis.1,2,4,6–8,12 The high
prevalence of C. albicans may be explained by the
great capacity of this species to adhere to the oral
mucosa5,8–10,18,25 and particularly to the surface of
acrylic denture base resins.4–6,8,10,13,14,18,19,25 Over the
past decades, an increase in non-albicans Candida spe-
cies in individuals diagnosed with denture stomatitis
has been observed.1,2,4,6,8,12 In the present study, in
addition to C. albicans species, several others were
identified. Among them, C. tropicalis and C. glabrata
were present in 25% and 22% of the individuals as-
sessed, respectively. The high prevalence of these 2
non-albicans species should not be neglected, because
they are associated with systemic infection (candi-
demia) as well as with a higher mortality rate than C.
albicans.51,52 Moreover, the presence of mixed popu-
lations of Candida spp. was observed in 48.3% of the
individuals in the present study. The most frequent
associations involved the species C. albicans, C.
glabrata, and C. tropicalis. These findings demon-
strated that these microorganisms were not only grow-
ing as single-species biofilms, but also as structured
biofilm communities, in both palates and dentures. This
points to the importance of biofilm development by
different species of Candida in the pathogenesis of
denture stomatitis. Biofilms may result in a higher
pathogenic potential and resistance to antifungal agents
and immune defense,53 facilitating the onset of the
infection.
Another important finding of the present study was
the higher microbiologic colonization of complete den-
tures compared with palatal mucosa. Thus, removable
dentures can be considered to be the main reservoirs of
microorganisms, particularly of Candida spp., and
eliminating these microorganisms from the surface of
the dentures is imperative in the prevention and treat-
ment of denture stomatitis. In addition, besides the
quantitative colonization, a relevant difference in the
qualitative colonization was found between dentures
and palates. The presence of 1 species of Candida
spp. was observed in 52.7% of the dentures of the
individuals assessed, compared with 34.8% obtained
from their palates. This could be due to the high ability
of Candida spp. to adhere to and colonize acrylic
surfaces.5,6,10 Irregularities of acrylic resin, such as
roughness and porosities, as well as hydrophobicity of
fungal cells, may facilitate the retention of microorgan-
isms, and thus dentures may act as a source of infection.
This information combined with the clinical and mi-
crobiologic results of the present study reinforces theneed that treatment of denture stomatitis should be
primarily directed to the dentures.
When assessed by clinical scoring, all treatments
were considered to be successful in treating patients
with denture stomatitis. The improvement of the clini-
cal signs of denture stomatitis was observed in 65% of
individuals, and 25% cured, at the end of the nystatin
treatment. Similarly, Bergendal and Isacsson15 ob-
served a significant reduction in erythematous areas of
the palatal mucosa after treating denture stomatitis with
nystatin. However, another study demonstrated that,
when miconazole was used, no changes in clinical signs
were observed.10 It was also found that the reduction in
clinical signs of denture stomatitis was more percepti-
ble in the palatal mucosa of individuals who had their
dentures submitted to the microwave disinfection pro-
cedure.10 This trend was seen in the present study,
where improvement in clinical signs occurred in 70%
and 75% of patients from the MW1 and MW3 groups,
respectively, and 
40% of were cured. During the
follow-up period, improvement in clinical signs was
maintained until day 90 for 43% of the patients from
the NYS group and 58% and 60% of the patients from
the MW1 and MW3 groups, respectively. This finding
may be attributed to the reduction of fungal load from
dentures and palates after the treatments associated
with the patient compliance with the recommendations
about oral and denture hygiene, including removing
dentures for sleeping. Despite the relevant scores of
improvement and cure of the infection, at the end of the
follow-up period (day 90), recurrence of denture sto-
matitis was observed in almost 53%, 39%, and 50% of
patients from the MW1, MW3, and NYS groups, re-
spectively. This finding is in agreement with that re-
ported by Banting and Hill,14 who reported a recurrence
rate of 56%. On the other hand, in the study of Nep-
pelenbroek et al.,10 the recurrence of denture stomatitis
was not clinically observed in any of the participants; at
the end of treatment (30 days), intraoral photographs
obtained from patients who had their dentures irradi-
ated were not different from those observed in other
evaluation periods (60 and 90 days). It is important to
emphasize that in that study the dentures were submit-
ted to 12 disinfection cycles, whereas in the present
study, they were submitted to a maximum of 6 cycles.
Recurrence of denture stomatitis may be related to
failure in eradicating the colonizing strain or reinfection
by an exogenous strain. In addition, denture wearers are
also Candida carriers even in the absence of clinical
signs of infection,2,4,6 which may lead to recontamina-
tion of the dentures and reinfection of the palatal mu-
cosa.
The results of this clinical study can be of great
interest to dentistry, because they indicate that micro-
ORAL MEDICINE OOOO
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an effective method for inactivating biofilm from the
denture surfaces. Because microwave irradiation is a
physical disinfection method, there may be no risk of
inducing resistance of microorganisms. Its use prevents
the undesirable effects of using antifungal agents, such
as nausea, vomiting, and hepatotoxic and nephrotoxic
effects,20 in addition to being a simple, safe, and low-
cost method. Moreover, considering that the microwave
irradiation of dentures inactivates all microorganisms
present in the biofilm,25 the method can be widely used
to prevent not only the denture stomatitis but systemic
diseases caused by pathogenic microorganisms present
in the denture biofilm, such as fungemia and aspiration
pneumonia.51,52,54
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